Bardin, Thomas http://orcid.org/0000-0002-5080-4790
Richette, Pascal
Article History
First Online: 20 July 2020
Competing interests
: T.B. declares that he has received advisory fees from AstraZeneca, Grunenthal and Novartis, and educational presentation fees from Astellas, Grunenthal and Novartis. P.R. declares that he has received fees from AstraZeneca, Ipsen Pharma/Menarini and Savient.